Discrepancies in office and ambulatory blood pressure in adolescents: help or hindrance?

PubWeight™: 0.75‹?›

🔗 View Article (PMID 17694335)

Published in Pediatr Nephrol on August 11, 2007

Authors

Empar Lurbe, Josep Redon

Articles cited by this

The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics (2004) 31.85

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet (1990) 25.12

Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Pediatrics (1996) 6.29

How common is white coat hypertension? JAMA (1988) 4.42

The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med (1988) 3.75

Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension (2006) 3.60

Report of the Second Task Force on Blood Pressure Control in Children--1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland. Pediatrics (1987) 3.43

Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA (2004) 3.35

Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens (2002) 3.21

Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: the Bogalusa Heart Study. Am J Hypertens (1995) 3.07

Cardiovascular health in childhood: A statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation (2002) 2.96

Masked hypertension. Hypertension (2002) 2.57

Dippers and non-dippers. Lancet (1988) 2.28

Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation (2003) 1.62

Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension (2005) 1.61

Heart rate and the cardiovascular risk. J Hypertens (1997) 1.57

Ambulatory blood pressure monitoring in the pediatric patient. J Pediatr (2000) 1.47

Continuous recording of direct arterial pressure in unrestricted patients. Its role in the diagnosis and management of high blood pressure. Circulation (1975) 1.37

White-coat and masked hypertension in children: association with target-organ damage. Pediatr Nephrol (2005) 1.24

Overweight and hypertension : a 2-way street? Hypertension (2000) 1.15

Clinical and research aspects of ambulatory blood pressure monitoring in children. J Pediatr (2004) 1.10

Evaluation of white coat hypertension in children: importance of the definitions of normal ambulatory blood pressure and the severity of casual hypertension. Am J Hypertens (2001) 1.08

Influence of diurnal blood pressure variations on target organ abnormalities in adolescents with mild essential hypertension. Am J Hypertens (1998) 1.08

The impact of the degree of obesity on the discrepancies between office and ambulatory blood pressure values in youth. J Hypertens (2006) 0.93

'White coat' hypertension in children. J Fam Pract (1991) 0.88

Ambulatory blood pressure measurement is indispensable to good clinical practice. J Hypertens Suppl (2003) 0.88

Ambulatory blood pressure monitoring in normotensive children. J Hypertens (1994) 0.85

Childhood blood pressure: a window to adult hypertension. J Hypertens (2003) 0.83

Validity and usefulness of non-invasive ambulatory blood pressure monitoring. J Hypertens Suppl (1985) 0.81

Unmasking hypertension. Hypertension (2005) 0.78

Compared with whom? Addressing the prognostic value of ambulatory blood pressure categories. Hypertension (2006) 0.75

Articles by these authors

2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43

European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens (2003) 5.94

Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med (2002) 5.72

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens (2009) 4.87

European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens (2013) 4.28

Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension (2009) 3.93

European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens (2008) 3.32

Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens (2005) 3.15

Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens (2009) 3.13

Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens (2009) 2.68

2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension. Blood Press (2013) 2.62

Added impact of obesity and insulin resistance in nocturnal blood pressure elevation in children and adolescents. Hypertension (2008) 2.31

ESH position paper: renal denervation - an interventional therapy of resistant hypertension. J Hypertens (2012) 2.24

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J (2016) 2.09

Ambulatory blood pressure values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET). Hypertension (2012) 2.02

Carotid-femoral pulse wave velocity assessment by two different methods: implications for risk assessment. J Hypertens (2015) 1.98

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press (2009) 1.98

Antihypertensive activity of angiotensin II AT1 receptor antagonists: a systematic review of studies with 24 h ambulatory blood pressure monitoring. J Hypertens (2007) 1.86

Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET). Circulation (2011) 1.77

Microvascular brain damage with aging and hypertension: pathophysiological consideration and clinical implications. J Hypertens (2011) 1.76

Blood pressure and obesity exert independent influences on pulse wave velocity in youth. Hypertension (2012) 1.70

Influence of concurrent obesity and low birth weight on blood pressure phenotype in youth. Hypertension (2009) 1.64

Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension (2005) 1.61

European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens (2014) 1.58

Associations of birth weight and postnatal weight gain with cardiometabolic risk parameters at 5 years of age. Hypertension (2014) 1.52

Association of central and peripheral pulse pressure with intermediate cardiovascular phenotypes. J Hypertens (2012) 1.49

2016 European Guidelines on cardiovascular disease prevention in clinical practice. Rev Esp Cardiol (Engl Ed) (2016) 1.42

Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment. J Hypertens (2013) 1.39

Hypertension in children and adolescents. J Hypertens (2004) 1.38

[Renal function as a prognostic marker of mortality in heart failure]. Med Clin (Barc) (2009) 1.38

The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome. J Hypertens (2008) 1.18

High blood pressure in children: clinical and health policy implications. J Clin Hypertens (Greenwich) (2010) 1.18

Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference. Kidney Int (2009) 1.16

Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial. J Hypertens (2014) 1.03

Procedure to consistently obtain endothelial and smooth muscle cell cultures from umbilical cord vessels. Transl Res (2007) 1.00

Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study. J Hypertens (2013) 0.94

The impact of the degree of obesity on the discrepancies between office and ambulatory blood pressure values in youth. J Hypertens (2006) 0.93

Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group 'Hypertension Arrhythmias and Thrombosis' of the European Society of Hypertension. J Hypertens (2012) 0.93

Metabolomic profiling in blood from umbilical cords of low birth weight newborns. J Transl Med (2012) 0.93

What the interventionalist should know about renal denervation in hypertensive patients: a position paper by the ESH WG on the interventional treatment of hypertension. EuroIntervention (2014) 0.92

Common variants of the liver fatty acid binding protein gene influence the risk of type 2 diabetes and insulin resistance in Spanish population. PLoS One (2012) 0.92

European Society of Hypertension Working Group on Obesity Obesity-induced hypertension and target organ damage: current knowledge and future directions. J Hypertens (2009) 0.91

[ESH/ESC 2007 Guidelines for the management of arterial hypertension]. Rev Esp Cardiol (2007) 0.90

Inadequate cytoplasmic antioxidant enzymes response contributes to the oxidative stress in human hypertension. Am J Hypertens (2007) 0.88

Eponym : Grisel syndrome. Eur J Pediatr (2011) 0.88

Drug utilization and off-label drug use among Spanish emergency room paediatric patients. Eur J Clin Pharmacol (2010) 0.87

Xanthine oxidoreductase polymorphisms: influence in blood pressure and oxidative stress levels. Pharmacogenet Genomics (2007) 0.86

Renin polymorphisms and haplotypes are associated with blood pressure levels and hypertension risk in postmenopausal women. J Hypertens (2008) 0.86

Determinants of urinary albumin excretion reduction in essential hypertension: A long-term follow-up study. J Hypertens (2006) 0.85

Exercise intervention in childhood obesity: a randomized controlled trial comparing hospital-versus home-based groups. Acad Pediatr (2012) 0.85

Birth weight and characteristics of endothelial and smooth muscle cell cultures from human umbilical cord vessels. J Transl Med (2009) 0.85

Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence. J Hypertens (2014) 0.85

Agreement within Europe about antihypertensive treatment and education - results from the European Society of Hypertension questionnaire. J Hypertens (2010) 0.84

New developments in the pathogenesis of obesity-induced hypertension. J Hypertens (2015) 0.84

Association of a mineralocorticoid receptor gene polymorphism with hypertension in a Spanish population. Am J Hypertens (2009) 0.84

2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens (2016) 0.83

Updated ESH position paper on interventional therapy of resistant hypertension. EuroIntervention (2013) 0.83

Childhood blood pressure: a window to adult hypertension. J Hypertens (2003) 0.83

Are physicians underestimating the challenges of hypertension management? Results from the Supporting Hypertension Awareness and Research Europe-wide (SHARE) survey. Eur J Prev Cardiol (2012) 0.83

Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke. J Hypertens (2016) 0.83

Nocturnal blood pressure versus nondipping pattern: what do they mean? Hypertension (2007) 0.83

Rationale and methods of the cardiometabolic Valencian study (Escarval-Risk) for validation of risk scales in Mediterranean patients with hypertension, diabetes or dyslipidemia. BMC Public Health (2010) 0.82

Polymorphisms of the UCP2 gene are associated with body fat distribution and risk of abdominal obesity in Spanish population. Eur J Clin Invest (2011) 0.82

Measurement of microalbuminuria--what the nephrologist should know. Nephrol Dial Transplant (2005) 0.81

Long-term impact of systolic blood pressure and glycemia on the development of microalbuminuria in essential hypertension. Hypertension (2005) 0.81

The impact of birth weight on pulse pressure during adolescence. Blood Press Monit (2004) 0.81

Dietary polyunsaturated fatty acids may increase plasma LDL-cholesterol and plasma cholesterol concentrations in carriers of an ABCG1 gene single nucleotide polymorphism: study in two Spanish populations. Atherosclerosis (2011) 0.80

Prevalence and factors related to urinary albumin excretion in obese youths. J Hypertens (2013) 0.79

Reference blood pressure values in childhood: an issue to be solved. J Hypertens (2012) 0.79

European Society of Hypertension Working Group on Obesity: background, aims and perspectives. J Hypertens (2007) 0.79

Genetic bases of urinary albumin excretion and related traits in hypertension. J Hypertens (2010) 0.79

[Practice guidelines 2007 for the treatment of arterial hypertension]. G Ital Cardiol (Rome) (2007) 0.79

Diagnosis and treatment of hypertension in children. Curr Hypertens Rep (2010) 0.79

The effects of telmisartan alone or with hydrochlorothiazide on morning and 24-h ambulatory BP control: results from a practice-based study (SURGE 2). Hypertens Res (2012) 0.79

The kidney in obesity. Curr Hypertens Rep (2015) 0.79

Treatment of hypertension and the price to pay; adverse events and discontinuation from randomized treatment in clinical trials. J Hypertens (2016) 0.78

Different impacts of cardiovascular risk factors on oxidative stress. Int J Mol Sci (2011) 0.78

[Differences between office and ambulatory control of hypertension in very elderly patients. The CARDIORISC - MAPAPRES project]. Med Clin (Barc) (2009) 0.78

Predictors of progression in hypertensive renal disease in children. J Clin Hypertens (Greenwich) (2004) 0.78

Hypertension and target organ damage in children and adolescents. J Hypertens (2007) 0.78

Increased oxidative stress levels and normal antioxidant enzyme activity in circulating mononuclear cells from patients of familial hypercholesterolemia. Metabolism (2009) 0.78

Urinary albumin excretion: lowering the threshold of risk in hypertension. Hypertension (2005) 0.77

Sexual dimorphism in the transition from masked to sustained hypertension in healthy youths. Hypertension (2013) 0.77

Body weight variation and control of cardiovascular risk factors in essential hypertension. Blood Press (2009) 0.77

Nocturnal hypertension: will control of nighttime blood pressure prevent progression of diabetic renal disease? Curr Hypertens Rep (2004) 0.77

Methodology and technology for peripheral and central blood pressure and blood pressure variability measurement: current status and future directions - Position statement of the European Society of Hypertension Working Group on blood pressure monitoring and cardiovascular variability. J Hypertens (2016) 0.77

Microalbuminuria in essential hypertension: redefining the threshold. J Hypertens (2002) 0.77

Association of selected ABC gene family single nucleotide polymorphisms with postprandial lipoproteins: results from the population-based Hortega study. Atherosclerosis (2010) 0.77

Reproducibility and validity of ambulatory blood pressure monitoring in children. Am J Hypertens (2002) 0.77

Gender differences related to the presence of atrial fibrillation in older hypertensive patients. World J Cardiol (2013) 0.77

Impaired exercise tolerance is associated with increased urine albumin excretion in the early stages of essential hypertension. Eur J Prev Cardiol (2011) 0.77